JFS WEALTH ADVISORS, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$0
-100.0%
2000.0%0.00%
Q1 2017$1,0000.0%2000.0%0.00%
Q4 2016$1,0000.0%2000.0%0.00%
Q3 2016$1,0000.0%2000.0%0.00%
Q2 2016$1,000
-50.0%
2000.0%0.00%
-100.0%
Q1 2016$2,0000.0%2000.0%0.00%0.0%
Q4 2015$2,0000.0%2000.0%0.00%0.0%
Q3 2015$2,0000.0%2000.0%0.00%0.0%
Q2 2015$2,0000.0%2000.0%0.00%0.0%
Q1 2015$2,0000.0%2000.0%0.00%
Q4 2014$2,000
+100.0%
200
+100.0%
0.00%
Q3 2014$1,0001000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,244,080$12,096,0004.51%
ALTFEST L J & CO INC 39,491$1,653,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 82,700$446,0000.44%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,074,557$48,912,0000.40%
Virtus ETF Advisers LLC 87,477$472,0000.35%
Cannell & Co. 1,614,678$8,703,0000.32%
Birchview Capital, LP 44,000$237,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 180,534$973,0000.14%
HighPoint Advisor Group LLC 8,484$344,0000.12%
MARINER INVESTMENT GROUP LLC 63,090$340,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders